Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

When A Single Shot Is A Problem: J&J’s Study Of Two Doses Raises Equality, Distribution Questions

Mar 01 2021

• By Derrick Gingery

Related Content

ACIP Shies Away From COVID-19 Vaccine Comparative Efficacy And Safety Evaluations

Mar 01 2021

Turning COVID-19 Vaccine EUA Into A BLA Will Require Six Months Of Additional Data

Mar 01 2021

The Evolution Of US FDA Advisory Committee Votes On COVID-19 Vaccines

Mar 01 2021

As FDA Advisers Grow Comfortable With EUAs, Harder Decisions On J&J’s Vaccine Fall To States, Individuals

Mar 01 2021

COVID-19 Vaccine Race: With Moderna EUA, US FDA Finally Gets Some Bragging Rights

Dec 21 2020

Related Companies

Johnson & Johnson

Janssen Biotech Inc.

Pfizer Inc.

BioNTech SE

Moderna, Inc.

Additional Topics

United States Coronavirus COVID-19 Vaccines Clinical Trials Regulation Advisory Committees BioPharmaceutical

More from Vaccines

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window